P Hovind, P Rossing, RJ Johnson… - Journal of Renal Nutrition, 2011 - Elsevier ... 13 P. Hovind, P. Rossing and L. Tarnow et al., Serum uric acid as a predictor for development of diabetic nephropathy in type 1 diabetes: an ... 14 DI Jalal, CJ Rivard and RJ Johnson et al., Serum uric acid levels predict the development of albuminuria over 6 years in patients with ... Related articles - All 3 versions
…, F Persson, I Ferreira, P Rossing… - Nephrology Dialysis …, 2011 - ERA-EDTA ... Plasma levels of CML and CEL did not change significantly over time in either group and did not differ between groups (Figure 1). Specifically, overall differences between irbesartan versus placebo throughout the course of follow-up were ... 20.↵: Persson F,; Rossing P,; Hovind P ... Related articles - All 2 versions
[PDF] from cpnc.dk…, F PERSSON, HH PARVING, P ROSSING… - Diabetes care, 2011 - cpnc.dk ... ESPEN JIMENEZ-SOLEM, MD 1,2 FREDERIK PERSSON, MD 3 HANS-HENRIK PARVING, DMSC 4,5,6 PETER ROSSING, DMSC 3 HENRIK E ... interaction was seen (treatment 3 time effect, P = 0.46), reflecting no treatment- related differences in the rate of change over time (Fig ... Related articles - View as HTML - All 5 versions
[PDF] from sheridan.com…, F PERSSON, SJL BAKKER, P ROSSING… - Diabetes Care, 2011 - sheridan.com ... MEREL E. HELLEMONS, MD 1 FREDERIK PERSSON, MD 2 STEPHAN JL BAKKER, MD, PHD 1 PETER ROSSING, MD, DMSC 2 ... persistent microalbuminuria, which was defined as a UAE rate of 20 to 200 μg/min in at least two out of three consecutive, sterile, over- night urine ... View as HTML
沪公网安备号：31010402006960 （网站）31010405000484 （蝌蝌APP）
安全保密
